Chemometric approaches to improve PLSDA model outcome for predicting human non-alcoholic fatty liver disease using UPLC-MS as a metabolic profiling tool
暂无分享,去创建一个
Alberto Ferrer | Juan Carlos García-Cañaveras | Agustín Lahoz | José Vicente Castell | Guillermo Quintás | J. Castell | A. Lahoz | J. C. García-Cañaveras | Nuria Portillo | Guillermo Quintás | Nuria Portillo | Alberto Ferrer
[1] José Vicente Castell,et al. A human hepatocellular in vitro model to investigate steatosis. , 2007, Chemico-biological interactions.
[2] P. Newsome,et al. Pathogenesis of non-alcoholic fatty liver disease , 2009, QJM : monthly journal of the Association of Physicians.
[3] Timothy M. D. Ebbels,et al. Genetic algorithms for simultaneous variable and sample selection in metabonomics , 2009, Bioinform..
[4] M. Viant,et al. High-throughput tissue extraction protocol for NMR- and MS-based metabolomics. , 2008, Analytical biochemistry.
[5] Age K. Smilde,et al. UvA-DARE ( Digital Academic Repository ) Assessment of PLSDA cross validation , 2008 .
[6] Kun Wook Chung,et al. Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytess⃞s⃞ The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of three figures. Published, JLR Papers in Press, October 18, 2007. , 2008, Journal of Lipid Research.
[7] Hisao Ishibuchi,et al. Repeated double cross-validation for choosing a single solution in evolutionary multi-objective fuzzy classifier design , 2013, Knowl. Based Syst..
[8] Richard G. Brereton,et al. Chemometrics for Pattern Recognition , 2009 .
[9] Vincent Baeten,et al. A Backward Variable Selection method for PLS regression (BVSPLS). , 2009, Analytica chimica acta.
[10] K. Sjoedin. Minimizing effects of closure on analytical data , 1984 .
[11] Christopher Herbert,et al. Liquid Chromatography/Mass Spectrometry (LC/MS) , 2002 .
[12] A. Smilde,et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. , 2006, Analytical chemistry.
[13] Jesús Brezmes,et al. Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease. , 2010, Journal of proteome research.
[14] R. A. van den Berg,et al. Centering, scaling, and transformations: improving the biological information content of metabolomics data , 2006, BMC Genomics.
[15] Richard G Brereton,et al. Variable selection using iterative reformulation of training set models for discrimination of samples: application to gas chromatography/mass spectrometry of mouse urinary metabolites. , 2009, Analytical chemistry.
[16] Wei Li,et al. Bile acids metabonomic study on the CCl4- and alpha-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry. , 2008, Chemical research in toxicology.
[17] C. Jun,et al. Performance of some variable selection methods when multicollinearity is present , 2005 .
[18] Joshua D. Knowles,et al. Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. , 2009, Analytical chemistry.
[19] Johan Trygg,et al. CV‐ANOVA for significance testing of PLS and OPLS® models , 2008 .
[20] M. Hirai,et al. MassBank: a public repository for sharing mass spectral data for life sciences. , 2010, Journal of mass spectrometry : JMS.
[21] A. Höskuldsson. Variable and subset selection in PLS regression , 2001 .
[22] B. Efron,et al. A Leisurely Look at the Bootstrap, the Jackknife, and , 1983 .
[23] Michelle M Wiest,et al. The plasma lipidomic signature of nonalcoholic steatohepatitis , 2009, Hepatology.
[24] M. Barker,et al. Partial least squares for discrimination , 2003 .
[25] Lennart Eriksson,et al. Model validation by permutation tests: Applications to variable selection , 1996 .
[26] Kishore K. Pasikanti,et al. Noninvasive urinary metabonomic diagnosis of human bladder cancer. , 2010, Journal of proteome research.
[27] Harold I Feldman,et al. Plasma metabolomic profiles in different stages of CKD. , 2013, Clinical journal of the American Society of Nephrology : CJASN.
[28] Isabelle Guyon,et al. An Introduction to Variable and Feature Selection , 2003, J. Mach. Learn. Res..
[29] Ping Liu,et al. Urinary metabolomics as a potentially novel diagnostic and stratification tool for knee osteoarthritis , 2010, Metabolomics.
[30] Shelly C. Lu,et al. Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. , 2010, Journal of proteome research.
[31] M. Milburn,et al. Plasma metabolomic profile in nonalcoholic fatty liver disease. , 2011, Metabolism: clinical and experimental.
[32] Matej Oresic,et al. Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles , 2007, ISMB/ECCB.
[33] Sonja Peters,et al. Parameter selection for peak alignment in chromatographic sample profiling: objective quality indicators and use of control samples , 2009, Analytical and bioanalytical chemistry.
[34] Paul Geladi,et al. Principles of Proper Validation: use and abuse of re‐sampling for validation , 2010 .
[35] S. Wold,et al. PLS-regression: a basic tool of chemometrics , 2001 .
[36] J. Romijn,et al. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[37] S Bhattacharjee,et al. Chemometrics in Analytical Chemistry , 1994 .
[38] A. Sanyal,et al. Recent advances in nonalcoholic fatty liver disease , 2010, Current opinion in gastroenterology.
[39] E. Want,et al. Global metabolic profiling procedures for urine using UPLC–MS , 2010, Nature Protocols.
[40] A. Sanyal,et al. Recent advances in nonalcoholic fatty liver disease , 2009, Current opinion in gastroenterology.
[41] Age K. Smilde,et al. Discriminant Q2 (DQ2) for improved discrimination in PLSDA models , 2008, Metabolomics.
[42] J. Lindon,et al. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.
[43] J. Castell,et al. Exploring mass spectrometry suitability to examine human liver graft metabonomic profiles. , 2010, Transplantation proceedings.
[44] David S. Wishart,et al. HMDB: a knowledgebase for the human metabolome , 2008, Nucleic Acids Res..